Treatment of refractory erythroderma with apremilast.

Autor: Manzoor, Hina, Sanai, Madiha, Ahmad, Afshan, Azad, Maria, Asghar, Aneela
Předmět:
Zdroj: Journal of Pakistan Association of Dermatologists; Jan-Mar2024, Vol. 34 Issue 1, p283-285, 3p
Abstrakt: Erythroderma is an exfoliative dermatitis with erythema involving more than 90% of body surface area. It has many causes which should be rule out to confirm diagnosis. Apremilast is inhibitor of phosphodiesterase 4 (PDE-4) which targets intracellularly cascade for anti-inflammatory effect. Here, we present a case of 55years old male in erythroderma with history of psoriasis who did not respond to conventional treatment of psoriatic erythroderma with phototherapy, methotrexate and acetretin but underwent almost complete remission after apremilast treatment. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index